Cargando…

Drosophila insulin and target of rapamycin (TOR) pathways regulate GSK3 beta activity to control Myc stability and determine Myc expression in vivo

BACKGROUND: Genetic studies in Drosophila melanogaster reveal an important role for Myc in controlling growth. Similar studies have also shown how components of the insulin and target of rapamycin (TOR) pathways are key regulators of growth. Despite a few suggestions that Myc transcriptional activit...

Descripción completa

Detalles Bibliográficos
Autores principales: Parisi, Federica, Riccardo, Sara, Daniel, Margaret, Saqcena, Mahesh, Kundu, Nandini, Pession, Annalisa, Grifoni, Daniela, Stocker, Hugo, Tabak, Esteban, Bellosta, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235970/
https://www.ncbi.nlm.nih.gov/pubmed/21951762
http://dx.doi.org/10.1186/1741-7007-9-65
_version_ 1782218665800761344
author Parisi, Federica
Riccardo, Sara
Daniel, Margaret
Saqcena, Mahesh
Kundu, Nandini
Pession, Annalisa
Grifoni, Daniela
Stocker, Hugo
Tabak, Esteban
Bellosta, Paola
author_facet Parisi, Federica
Riccardo, Sara
Daniel, Margaret
Saqcena, Mahesh
Kundu, Nandini
Pession, Annalisa
Grifoni, Daniela
Stocker, Hugo
Tabak, Esteban
Bellosta, Paola
author_sort Parisi, Federica
collection PubMed
description BACKGROUND: Genetic studies in Drosophila melanogaster reveal an important role for Myc in controlling growth. Similar studies have also shown how components of the insulin and target of rapamycin (TOR) pathways are key regulators of growth. Despite a few suggestions that Myc transcriptional activity lies downstream of these pathways, a molecular mechanism linking these signaling pathways to Myc has not been clearly described. Using biochemical and genetic approaches we tried to identify novel mechanisms that control Myc activity upon activation of insulin and TOR signaling pathways. RESULTS: Our biochemical studies show that insulin induces Myc protein accumulation in Drosophila S2 cells, which correlates with a decrease in the activity of glycogen synthase kinase 3-beta (GSK3β ) a kinase that is responsible for Myc protein degradation. Induction of Myc by insulin is inhibited by the presence of the TOR inhibitor rapamycin, suggesting that insulin-induced Myc protein accumulation depends on the activation of TOR complex 1. Treatment with amino acids that directly activate the TOR pathway results in Myc protein accumulation, which also depends on the ability of S6K kinase to inhibit GSK3β activity. Myc upregulation by insulin and TOR pathways is a mechanism conserved in cells from the wing imaginal disc, where expression of Dp110 and Rheb also induces Myc protein accumulation, while inhibition of insulin and TOR pathways result in the opposite effect. Our functional analysis, aimed at quantifying the relative contribution of Myc to ommatidial growth downstream of insulin and TOR pathways, revealed that Myc activity is necessary to sustain the proliferation of cells from the ommatidia upon Dp110 expression, while its contribution downstream of TOR is significant to control the size of the ommatidia. CONCLUSIONS: Our study presents novel evidence that Myc activity acts downstream of insulin and TOR pathways to control growth in Drosophila. At the biochemical level we found that both these pathways converge at GSK3β to control Myc protein stability, while our genetic analysis shows that insulin and TOR pathways have different requirements for Myc activity during development of the eye, suggesting that Myc might be differentially induced by these pathways during growth or proliferation of cells that make up the ommatidia.
format Online
Article
Text
id pubmed-3235970
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32359702011-12-13 Drosophila insulin and target of rapamycin (TOR) pathways regulate GSK3 beta activity to control Myc stability and determine Myc expression in vivo Parisi, Federica Riccardo, Sara Daniel, Margaret Saqcena, Mahesh Kundu, Nandini Pession, Annalisa Grifoni, Daniela Stocker, Hugo Tabak, Esteban Bellosta, Paola BMC Biol Research Article BACKGROUND: Genetic studies in Drosophila melanogaster reveal an important role for Myc in controlling growth. Similar studies have also shown how components of the insulin and target of rapamycin (TOR) pathways are key regulators of growth. Despite a few suggestions that Myc transcriptional activity lies downstream of these pathways, a molecular mechanism linking these signaling pathways to Myc has not been clearly described. Using biochemical and genetic approaches we tried to identify novel mechanisms that control Myc activity upon activation of insulin and TOR signaling pathways. RESULTS: Our biochemical studies show that insulin induces Myc protein accumulation in Drosophila S2 cells, which correlates with a decrease in the activity of glycogen synthase kinase 3-beta (GSK3β ) a kinase that is responsible for Myc protein degradation. Induction of Myc by insulin is inhibited by the presence of the TOR inhibitor rapamycin, suggesting that insulin-induced Myc protein accumulation depends on the activation of TOR complex 1. Treatment with amino acids that directly activate the TOR pathway results in Myc protein accumulation, which also depends on the ability of S6K kinase to inhibit GSK3β activity. Myc upregulation by insulin and TOR pathways is a mechanism conserved in cells from the wing imaginal disc, where expression of Dp110 and Rheb also induces Myc protein accumulation, while inhibition of insulin and TOR pathways result in the opposite effect. Our functional analysis, aimed at quantifying the relative contribution of Myc to ommatidial growth downstream of insulin and TOR pathways, revealed that Myc activity is necessary to sustain the proliferation of cells from the ommatidia upon Dp110 expression, while its contribution downstream of TOR is significant to control the size of the ommatidia. CONCLUSIONS: Our study presents novel evidence that Myc activity acts downstream of insulin and TOR pathways to control growth in Drosophila. At the biochemical level we found that both these pathways converge at GSK3β to control Myc protein stability, while our genetic analysis shows that insulin and TOR pathways have different requirements for Myc activity during development of the eye, suggesting that Myc might be differentially induced by these pathways during growth or proliferation of cells that make up the ommatidia. BioMed Central 2011-09-27 /pmc/articles/PMC3235970/ /pubmed/21951762 http://dx.doi.org/10.1186/1741-7007-9-65 Text en Copyright ©2011 Parisi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Parisi, Federica
Riccardo, Sara
Daniel, Margaret
Saqcena, Mahesh
Kundu, Nandini
Pession, Annalisa
Grifoni, Daniela
Stocker, Hugo
Tabak, Esteban
Bellosta, Paola
Drosophila insulin and target of rapamycin (TOR) pathways regulate GSK3 beta activity to control Myc stability and determine Myc expression in vivo
title Drosophila insulin and target of rapamycin (TOR) pathways regulate GSK3 beta activity to control Myc stability and determine Myc expression in vivo
title_full Drosophila insulin and target of rapamycin (TOR) pathways regulate GSK3 beta activity to control Myc stability and determine Myc expression in vivo
title_fullStr Drosophila insulin and target of rapamycin (TOR) pathways regulate GSK3 beta activity to control Myc stability and determine Myc expression in vivo
title_full_unstemmed Drosophila insulin and target of rapamycin (TOR) pathways regulate GSK3 beta activity to control Myc stability and determine Myc expression in vivo
title_short Drosophila insulin and target of rapamycin (TOR) pathways regulate GSK3 beta activity to control Myc stability and determine Myc expression in vivo
title_sort drosophila insulin and target of rapamycin (tor) pathways regulate gsk3 beta activity to control myc stability and determine myc expression in vivo
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235970/
https://www.ncbi.nlm.nih.gov/pubmed/21951762
http://dx.doi.org/10.1186/1741-7007-9-65
work_keys_str_mv AT parisifederica drosophilainsulinandtargetofrapamycintorpathwaysregulategsk3betaactivitytocontrolmycstabilityanddeterminemycexpressioninvivo
AT riccardosara drosophilainsulinandtargetofrapamycintorpathwaysregulategsk3betaactivitytocontrolmycstabilityanddeterminemycexpressioninvivo
AT danielmargaret drosophilainsulinandtargetofrapamycintorpathwaysregulategsk3betaactivitytocontrolmycstabilityanddeterminemycexpressioninvivo
AT saqcenamahesh drosophilainsulinandtargetofrapamycintorpathwaysregulategsk3betaactivitytocontrolmycstabilityanddeterminemycexpressioninvivo
AT kundunandini drosophilainsulinandtargetofrapamycintorpathwaysregulategsk3betaactivitytocontrolmycstabilityanddeterminemycexpressioninvivo
AT pessionannalisa drosophilainsulinandtargetofrapamycintorpathwaysregulategsk3betaactivitytocontrolmycstabilityanddeterminemycexpressioninvivo
AT grifonidaniela drosophilainsulinandtargetofrapamycintorpathwaysregulategsk3betaactivitytocontrolmycstabilityanddeterminemycexpressioninvivo
AT stockerhugo drosophilainsulinandtargetofrapamycintorpathwaysregulategsk3betaactivitytocontrolmycstabilityanddeterminemycexpressioninvivo
AT tabakesteban drosophilainsulinandtargetofrapamycintorpathwaysregulategsk3betaactivitytocontrolmycstabilityanddeterminemycexpressioninvivo
AT bellostapaola drosophilainsulinandtargetofrapamycintorpathwaysregulategsk3betaactivitytocontrolmycstabilityanddeterminemycexpressioninvivo